Literature DB >> 1861456

beta-mannosidase deficiency in a female infant with epileptic encephalopathy.

A Cooper1, J E Wraith, W J Savage, M Thornley, M J Noronha.   

Abstract

We report a female infant with an isolated deficiency of beta-mannosidase activity. At nine months of age dysmorphism was absent except for brachecephaly. There was moderate developmental delay and a startle response to sound. At 12 months there was a sudden onset of tonic-clonic seizures which were unresponsive to drug therapy, requiring paralysis and mechanical ventilation for control. The child died suddenly aged 15 months. beta-mannosidase activity was markedly reduced in white cells and cultured skin fibroblasts whilst other lysosomal enzymes were normal. The disaccharide ManGlcNAc was excreted in urine but urinary mucopolysaccharides were normal.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861456     DOI: 10.1007/bf01804383

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Human beta-mannosidase deficiency.

Authors:  D A Wenger; E Sujansky; P V Fennessey; J N Thompson
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

2.  Human beta-mannosidase deficiency.

Authors:  A Cooper; I B Sardharwalla; M M Roberts
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

3.  Beta-mannosidosis in two brothers with hearing loss.

Authors:  L Dorland; M Duran; F E Hoefnagels; J N Breg; H Fabery de Jonge; K Cransberg; F J van Sprang; O P van Diggelen
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  An improved thin-layer chromatographic method for urinary oligosaccharide screening.

Authors:  A C Sewell
Journal:  Clin Chim Acta       Date:  1979-03-15       Impact factor: 3.786

5.  beta-Mannosidase deficiency in Anglo Nubian goats.

Authors:  P F Healy; J T Seaman; I A Gardner; C A Sewell
Journal:  Aust Vet J       Date:  1981-11       Impact factor: 1.281

6.  Alpha- and beta-mannosidoses.

Authors:  A Cooper; C E Hatton; M Thornley; I B Sardharwalla
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

7.  Caprine beta-mannosidosis: clinical and pathological features.

Authors:  M Z Jones; J G Cunningham; A W Dade; D M Alessi; U V Mostosky; J R Vorro; J T Benitez; K L Lovell
Journal:  J Neuropathol Exp Neurol       Date:  1983-05       Impact factor: 3.685

8.  Caprine oligosaccharide storage disease. Accumulation of beta-mannosyl (1 goes to 4) beta-N-acetylglucosaminyl (1 goes to 4) beta-N-acetylglucosamine in brain.

Authors:  M Z Jones; R A Laine
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

9.  Caprine beta-mannosidosis. Inherited deficiency of beta-D-mannosidase.

Authors:  M Z Jones; G Dawson
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

10.  Human beta-mannosidase deficiency: biochemical findings in plasma, fibroblasts, white cells and urine.

Authors:  A Cooper; C Hatton; M Thornley; I B Sardharwalla
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

  10 in total
  7 in total

1.  A Clinically Severe Variant of β-Mannosidosis, Presenting with Neonatal Onset Epilepsy with Subsequent Evolution of Hydrocephalus.

Authors:  A Broomfield; R Gunny; I Ali; A Vellodi; P Prabhakar
Journal:  JIMD Rep       Date:  2013-04-16

2.  Bovine kidney beta-mannosidase: purification and characterization.

Authors:  B L Sopher; C E Traviss; K T Cavanagh; M Z Jones; K H Friderici
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

3.  Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants.

Authors:  Rainer Malik; Tobias Freilinger; Bendik S Winsvold; Verneri Anttila; Jason Vander Heiden; Matthew Traylor; Boukje de Vries; Elizabeth G Holliday; Gisela M Terwindt; Jonathan Sturm; Joshua C Bis; Jemma C Hopewell; Michel D Ferrari; Kristiina Rannikmae; Maija Wessman; Mikko Kallela; Christian Kubisch; Myriam Fornage; James F Meschia; Terho Lehtimäki; Cathie Sudlow; Robert Clarke; Daniel I Chasman; Braxton D Mitchell; Jane Maguire; Jaakko Kaprio; Martin Farrall; Olli T Raitakari; Tobias Kurth; M Arfan Ikram; Alex P Reiner; W T Longstreth; Peter M Rothwell; David P Strachan; Pankaj Sharma; Sudha Seshadri; Lydia Quaye; Lynn Cherkas; Markus Schürks; Jonathan Rosand; Lannie Ligthart; Giorgio B Boncoraglio; George Davey Smith; Cornelia M van Duijn; Kari Stefansson; Bradford B Worrall; Dale R Nyholt; Hugh S Markus; Arn M J M van den Maagdenberg; Chris Cotsapas; John A Zwart; Aarno Palotie; Martin Dichgans
Journal:  Neurology       Date:  2015-05-01       Impact factor: 9.910

4.  β-Mannosidosis caused by a novel homozygous intragenic inverted duplication in MANBA.

Authors:  Maria Blomqvist; Marie Falkenberg Smeland; Julia Lindgren; Per Sikora; Hilde Monica Frostad Riise Stensland; Jorge Asin-Cayuela
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

5.  A MANBA mutation resulting in residual beta-mannosidase activity associated with severe leukoencephalopathy: a possible pseudodeficiency variant.

Authors:  Frédérique Sabourdy; Pierre Labauge; Hilde Monica Frostad Riise Stensland; Michèle Nieto; Violeta Latorre Garcés; Dimitri Renard; Giovanni Castelnovo; Nicolas de Champfleur; Thierry Levade
Journal:  BMC Med Genet       Date:  2009-09-03       Impact factor: 2.103

6.  Beta-mannosidae deficiency in two mentally retarded girls with intractable seizures.

Authors:  Mathew Punnachalil Cherian
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

7.  Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant.

Authors:  Dana Safka Brozkova; Lukas Varga; Anna Uhrova Meszarosova; Zuzana Slobodova; Martina Skopkova; Andrea Soltysova; Andrej Ficek; Jan Jencik; Jana Lastuvkova; Daniela Gasperikova; Pavel Seeman
Journal:  Orphanet J Rare Dis       Date:  2020-08-26       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.